Shilpa Medicare’s Plan For Eylea Biosimilar Spells Ambition, But Path Not Easy

Humira Biosimilar Trial Recruiting

Arrow being aimed at man flying with arrow in hand
Shilpa's Biosimilars Ambitions Could Face Obstacles • Source: Alamy

More from R&D

More from Scrip